HEADER TRANSFERASE 26-JUL-06 2IZT TITLE STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASEIN KINASE I ISOFORM GAMMA-3; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 35-362; COMPND 5 SYNONYM: CKI-GAMMA 3, CASEIN KINASE 1 GAMMA 3; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PLIC-SGC KEYWDS TRANSFERASE, RANSFERASE, NUCLEOTIDE-BINDING, WNT SIGNALING PATHWAY EXPDTA X-RAY DIFFRACTION AUTHOR G.BUNKOCZI,E.SALAH,P.RELLOS,S.DAS,O.FEDOROV,P.SAVITSKY, AUTHOR 2 J.E.DEBRECZENI,O.GILEADI,M.SUNDSTROM,A.EDWARDS,C.ARROWSMITH, AUTHOR 3 J.WEIGELT,F.VON DELFT,S.KNAPP REVDAT 6 13-DEC-23 2IZT 1 REMARK REVDAT 5 04-APR-18 2IZT 1 REMARK REVDAT 4 24-JAN-18 2IZT 1 AUTHOR JRNL REVDAT 3 13-JUL-11 2IZT 1 VERSN REVDAT 2 24-FEB-09 2IZT 1 VERSN REVDAT 1 01-AUG-06 2IZT 0 JRNL AUTH G.BUNKOCZI,E.SALAH,P.RELLOS,S.DAS,O.FEDOROV,P.SAVITSKY, JRNL AUTH 2 J.E.DEBRECZENI,O.GILEADI,M.SUNDSTROM,A.EDWARDS,C.ARROWSMITH, JRNL AUTH 3 J.WEIGELT,F.VON DELFT,S.KNAPP JRNL TITL INHIBITOR BINDING BY CASEIN KINASES JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.35 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 91.7 REMARK 3 NUMBER OF REFLECTIONS : 24862 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.225 REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.277 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1333 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1634 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3860 REMARK 3 BIN FREE R VALUE SET COUNT : 80 REMARK 3 BIN FREE R VALUE : 0.4450 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2422 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 23 REMARK 3 SOLVENT ATOMS : 246 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : UNVERIFIED REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 10.38 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.06000 REMARK 3 B22 (A**2) : -0.06000 REMARK 3 B33 (A**2) : 0.10000 REMARK 3 B12 (A**2) : -0.03000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.208 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.193 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.163 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.918 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.921 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.872 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2572 ; 0.014 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1818 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3476 ; 1.527 ; 1.989 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4396 ; 0.981 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 302 ; 7.142 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 123 ;35.143 ;22.846 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 457 ;15.704 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 21 ;16.595 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 365 ; 0.084 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2821 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 566 ; 0.007 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 628 ; 0.199 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2105 ; 0.207 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1248 ; 0.189 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1406 ; 0.089 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 204 ; 0.189 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 19 ; 0.158 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 45 ; 0.249 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 12 ; 0.200 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1540 ; 2.150 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2434 ; 3.042 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1188 ; 5.131 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1041 ; 6.390 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 35 A 107 REMARK 3 ORIGIN FOR THE GROUP (A): 45.2771 -10.6788 28.7121 REMARK 3 T TENSOR REMARK 3 T11: -0.1521 T22: 0.0611 REMARK 3 T33: -0.0063 T12: -0.0044 REMARK 3 T13: -0.0260 T23: 0.0164 REMARK 3 L TENSOR REMARK 3 L11: 1.9171 L22: 2.4847 REMARK 3 L33: 2.1731 L12: -1.0542 REMARK 3 L13: 1.3880 L23: -1.1862 REMARK 3 S TENSOR REMARK 3 S11: -0.0196 S12: 0.2337 S13: 0.1153 REMARK 3 S21: 0.0970 S22: -0.2088 S23: -0.2092 REMARK 3 S31: -0.0881 S32: 0.1697 S33: 0.2284 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 108 A 322 REMARK 3 ORIGIN FOR THE GROUP (A): 25.2051 -5.6977 15.7053 REMARK 3 T TENSOR REMARK 3 T11: -0.0988 T22: -0.0302 REMARK 3 T33: -0.0904 T12: -0.0061 REMARK 3 T13: -0.0047 T23: -0.0145 REMARK 3 L TENSOR REMARK 3 L11: 1.3026 L22: 0.9056 REMARK 3 L33: 1.3444 L12: 0.0945 REMARK 3 L13: -0.2690 L23: -0.2971 REMARK 3 S TENSOR REMARK 3 S11: -0.0038 S12: 0.0751 S13: -0.0708 REMARK 3 S21: -0.1221 S22: -0.0484 S23: 0.0015 REMARK 3 S31: -0.0078 S32: -0.0061 S33: 0.0522 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2IZT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-JUL-06. REMARK 100 THE DEPOSITION ID IS D_1290029504. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-APR-06 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMIC HR MULTILAYER OPTICS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU IMAGE PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26655 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 32.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.0 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.10 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.6 REMARK 200 DATA REDUNDANCY IN SHELL : 2.50 REMARK 200 R MERGE FOR SHELL (I) : 0.36000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2CHL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.05 M CACL2, 20% PEG6000, 10% REMARK 280 ETHYLENE GLYCOL, 0.10 M TRIS PH=8.0, PH 8.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 73.42200 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 146.84400 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 146.84400 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 73.42200 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CASEIN KINASES ARE OPERATIONALLY DEFINED BY THEIR REMARK 400 PREFERENTIAL UTILIZATION OF ACIDIC PROTEINS SUCH AS CASEINS AS REMARK 400 SUBSTRATES. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 33 REMARK 465 MET A 34 REMARK 465 GLY A 35 REMARK 465 VAL A 36 REMARK 465 GLY A 52 REMARK 465 ASN A 53 REMARK 465 GLY A 335 REMARK 465 ALA A 336 REMARK 465 VAL A 337 REMARK 465 GLN A 338 REMARK 465 GLN A 339 REMARK 465 ASP A 340 REMARK 465 PRO A 341 REMARK 465 ALA A 342 REMARK 465 LEU A 343 REMARK 465 SER A 344 REMARK 465 SER A 345 REMARK 465 ASN A 346 REMARK 465 ARG A 347 REMARK 465 GLU A 348 REMARK 465 ALA A 349 REMARK 465 HIS A 350 REMARK 465 GLN A 351 REMARK 465 HIS A 352 REMARK 465 ARG A 353 REMARK 465 ASP A 354 REMARK 465 LYS A 355 REMARK 465 MET A 356 REMARK 465 GLN A 357 REMARK 465 GLN A 358 REMARK 465 SER A 359 REMARK 465 LYS A 360 REMARK 465 ASN A 361 REMARK 465 GLN A 362 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 48 CD CE NZ REMARK 470 PHE A 54 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 77 CD CE NZ REMARK 470 ARG A 79 CD NE CZ NH1 NH2 REMARK 470 LYS A 176 CG CD CE NZ REMARK 470 LYS A 198 CG CD CE NZ REMARK 470 LYS A 253 CD CE NZ REMARK 470 THR A 332 OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2006 O HOH A 2007 2.15 REMARK 500 OD1 ASP A 230 O HOH A 2167 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 135 153.94 -49.86 REMARK 500 ASP A 162 38.58 -142.46 REMARK 500 LYS A 164 141.14 178.01 REMARK 500 ASP A 185 81.44 67.99 REMARK 500 GLU A 205 -161.04 -124.44 REMARK 500 THR A 210 -28.86 -141.62 REMARK 500 ASN A 279 -8.99 87.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2043 DISTANCE = 7.65 ANGSTROMS REMARK 525 HOH A2044 DISTANCE = 6.19 ANGSTROMS REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 23D A 1335 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A1336 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A1337 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 23D A1335 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2CHL RELATED DB: PDB REMARK 900 STRUCTURE OF CASEIN KINASE 1 GAMMA 3 REMARK 900 RELATED ID: 2IZR RELATED DB: PDB REMARK 900 STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 2IZS RELATED DB: PDB REMARK 900 STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 2IZU RELATED DB: PDB REMARK 900 STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR DBREF 2IZT A 35 362 UNP Q9Y6M4 KC1G3_HUMAN 35 362 SEQADV 2IZT SER A 33 UNP Q9Y6M4 EXPRESSION TAG SEQADV 2IZT MET A 34 UNP Q9Y6M4 EXPRESSION TAG SEQADV 2IZT ALA A 187 UNP Q9Y6M4 GLY 187 CONFLICT SEQRES 1 A 330 SER MET GLY VAL LEU MET VAL GLY PRO ASN PHE ARG VAL SEQRES 2 A 330 GLY LYS LYS ILE GLY CYS GLY ASN PHE GLY GLU LEU ARG SEQRES 3 A 330 LEU GLY LYS ASN LEU TYR THR ASN GLU TYR VAL ALA ILE SEQRES 4 A 330 LYS LEU GLU PRO MET LYS SER ARG ALA PRO GLN LEU HIS SEQRES 5 A 330 LEU GLU TYR ARG PHE TYR LYS GLN LEU GLY SER GLY ASP SEQRES 6 A 330 GLY ILE PRO GLN VAL TYR TYR PHE GLY PRO CYS GLY LYS SEQRES 7 A 330 TYR ASN ALA MET VAL LEU GLU LEU LEU GLY PRO SER LEU SEQRES 8 A 330 GLU ASP LEU PHE ASP LEU CYS ASP ARG THR PHE SER LEU SEQRES 9 A 330 LYS THR VAL LEU MET ILE ALA ILE GLN LEU ILE SER ARG SEQRES 10 A 330 MET GLU TYR VAL HIS SER LYS ASN LEU ILE TYR ARG ASP SEQRES 11 A 330 VAL LYS PRO GLU ASN PHE LEU ILE GLY ARG PRO GLY ASN SEQRES 12 A 330 LYS THR GLN GLN VAL ILE HIS ILE ILE ASP PHE ALA LEU SEQRES 13 A 330 ALA LYS GLU TYR ILE ASP PRO GLU THR LYS LYS HIS ILE SEQRES 14 A 330 PRO TYR ARG GLU HIS LYS SER LEU THR GLY THR ALA ARG SEQRES 15 A 330 TYR MET SER ILE ASN THR HIS LEU GLY LYS GLU GLN SER SEQRES 16 A 330 ARG ARG ASP ASP LEU GLU ALA LEU GLY HIS MET PHE MET SEQRES 17 A 330 TYR PHE LEU ARG GLY SER LEU PRO TRP GLN GLY LEU LYS SEQRES 18 A 330 ALA ASP THR LEU LYS GLU ARG TYR GLN LYS ILE GLY ASP SEQRES 19 A 330 THR LYS ARG ALA THR PRO ILE GLU VAL LEU CYS GLU ASN SEQRES 20 A 330 PHE PRO GLU MET ALA THR TYR LEU ARG TYR VAL ARG ARG SEQRES 21 A 330 LEU ASP PHE PHE GLU LYS PRO ASP TYR ASP TYR LEU ARG SEQRES 22 A 330 LYS LEU PHE THR ASP LEU PHE ASP ARG LYS GLY TYR MET SEQRES 23 A 330 PHE ASP TYR GLU TYR ASP TRP ILE GLY LYS GLN LEU PRO SEQRES 24 A 330 THR PRO VAL GLY ALA VAL GLN GLN ASP PRO ALA LEU SER SEQRES 25 A 330 SER ASN ARG GLU ALA HIS GLN HIS ARG ASP LYS MET GLN SEQRES 26 A 330 GLN SER LYS ASN GLN HET 23D A1335 21 HET CL A1336 1 HET CL A1337 1 HETNAM 23D N2-[(1R,2S)-2-AMINOCYCLOHEXYL]-N6-(3-CHLOROPHENYL)-9- HETNAM 2 23D ETHYL-9H-PURINE-2,6-DIAMINE HETNAM CL CHLORIDE ION FORMUL 2 23D C19 H24 CL N7 FORMUL 3 CL 2(CL 1-) FORMUL 5 HOH *246(H2 O) HELIX 1 1 GLN A 82 GLY A 94 1 13 HELIX 2 2 SER A 122 CYS A 130 1 9 HELIX 3 3 SER A 135 LYS A 156 1 22 HELIX 4 4 LYS A 164 GLU A 166 5 3 HELIX 5 5 SER A 217 LEU A 222 1 6 HELIX 6 6 SER A 227 GLY A 245 1 19 HELIX 7 7 THR A 256 THR A 271 1 16 HELIX 8 8 PRO A 272 CYS A 277 1 6 HELIX 9 9 PHE A 280 LEU A 293 1 14 HELIX 10 10 ASP A 300 LYS A 315 1 16 SHEET 1 AA 6 MET A 38 VAL A 39 0 SHEET 2 AA 6 PHE A 43 GLY A 50 -1 O PHE A 43 N VAL A 39 SHEET 3 AA 6 GLU A 56 ASN A 62 -1 O LEU A 57 N ILE A 49 SHEET 4 AA 6 GLU A 67 PRO A 75 -1 O GLU A 67 N ASN A 62 SHEET 5 AA 6 TYR A 111 GLU A 117 -1 O ASN A 112 N GLU A 74 SHEET 6 AA 6 VAL A 102 CYS A 108 -1 N TYR A 103 O VAL A 115 SHEET 1 AB 2 LEU A 158 ILE A 159 0 SHEET 2 AB 2 LYS A 190 GLU A 191 -1 O LYS A 190 N ILE A 159 SHEET 1 AC 2 PHE A 168 ILE A 170 0 SHEET 2 AC 2 ILE A 181 ILE A 183 -1 O HIS A 182 N LEU A 169 SITE 1 AC1 3 THR A 212 ARG A 214 ARG A 260 SITE 1 AC2 3 LYS A 61 ASP A 97 ARG A 149 SITE 1 AC3 14 ILE A 49 LEU A 57 LEU A 116 GLU A 117 SITE 2 AC3 14 LEU A 119 GLY A 120 LEU A 169 ILE A 184 SITE 3 AC3 14 PRO A 331 THR A 332 PRO A 333 HOH A2069 SITE 4 AC3 14 HOH A2073 HOH A2246 CRYST1 56.433 56.433 220.266 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017720 0.010231 0.000000 0.00000 SCALE2 0.000000 0.020461 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004540 0.00000